Free Trial

BioCardia (BCDA) Short Interest Ratio & Short Volume

$0.35
+0.02 (+5.68%)
(As of 04:00 PM ET)

BioCardia Short Interest Data

Current Short Interest
262,800 shares
Previous Short Interest
271,200 shares
Change Vs. Previous Month
-3.10%
Dollar Volume Sold Short
$101,729.88
Short Interest Ratio
0.8 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
27,300,000 shares
Percentage of Shares Shorted
0.96%
Today's Trading Volume
306,818 shares
Average Trading Volume
294,551 shares
Today's Volume Vs. Average
104%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling BioCardia ?

Sign up to receive the latest short interest report for BioCardia and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BCDA Short Interest Over Time

BCDA Days to Cover Over Time

BCDA Percentage of Float Shorted Over Time

BioCardia Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2024262,800 shares $101,729.88 -3.1%N/A0.8 $0.39
4/15/2024271,200 shares $100,994.88 -49.4%N/A0.8 $0.37
3/31/2024535,900 shares $218,111.30 -46.9%N/A1.4 $0.41
3/15/20241,010,000 shares $393,900.00 +927.5%6.2%2.7 $0.39
2/29/202498,300 shares $54,065.00 -67.0%0.7%0.3 $0.55
2/15/2024297,600 shares $127,968.00 +84.2%2.5%1 $0.43
1/31/2024161,600 shares $73,237.12 +22.8%1.3%0.1 $0.45
1/15/2024131,600 shares $85,329.44 -39.2%1.1%0 $0.65
12/31/2023216,600 shares $143,865.72 -31.8%1.8%0.1 $0.66
12/15/2023317,800 shares $190,997.80 -9.0%2.7%0.1 $0.60
11/30/2023349,100 shares $216,860.92 +132.0%3.5%0.1 $0.62
11/15/2023150,500 shares $142,222.50 +13.4%1.5%0.1 $0.95
10/31/2023132,700 shares $49,404.21 -35.2%1.3%1.2 $0.37
10/15/2023204,900 shares $90,156.00 +9.8%2.1%1.5 $0.44
9/30/2023186,600 shares $80,219.34 +48.1%1.6%1.4 $0.43
9/15/2023126,000 shares $49,770.00 -36.7%1.1%0.9 $0.40
8/31/2023199,000 shares $155,220.00 +8.0%1.7%1.8 $0.78
8/15/2023184,300 shares $162,147.14 +575.1%1.5%1.9 $0.88
7/31/202327,300 shares $28,119.00 -84.0%0.2%0.3 $1.03
7/15/2023171,000 shares $398,430.00 -14.2%1.4%2.4 $2.33
6/30/2023199,400 shares $532,398.00 -4.3%1.6%5.1 $2.67
6/15/2023208,300 shares $477,007.00 +3.8%1.6%5.6 $2.29
5/31/2023200,600 shares $355,062.00 +1,443.1%1.6%6.9 $1.77
5/15/202313,000 shares $24,050.00 -29.4%0.1%0.5 $1.85
4/30/202318,400 shares $37,904.00 -12.0%0.1%0.9 $2.06
4/15/202320,900 shares $40,964.00 -23.7%0.1%0.9 $1.96
3/31/202327,400 shares $53,430.00 -26.9%0.2%1 $1.95
3/15/202337,500 shares $73,875.00 +4.8%0.3%1.2 $1.97
2/28/202335,800 shares $78,760.00 +96.7%0.3%0.7 $2.20
2/15/202318,200 shares $40,586.00 -56.6%0.1%0.4 $2.23
1/31/202341,900 shares $106,426.00 -4.3%0.3%0.9 $2.54
1/15/202343,800 shares $100,302.00 -15.4%0.4%1 $2.29
12/30/202251,800 shares $108,262.00 -40.6%0.4%1.2 $2.09
12/15/202287,200 shares $149,112.00 +149.1%0.7%2 $1.71
11/30/202235,000 shares $64,750.00 +44.0%0.2%0.8 $1.85
11/15/202224,300 shares $45,684.00 -42.1%0.2%0.5 $1.88
10/31/202242,000 shares $81,900.00 -24.5%0.3%0.7 $1.95
10/15/202255,600 shares $116,204.00 -37.3%0.4%0.9 $2.09
9/30/202288,600 shares $171,884.00 -7.2%0.7%1.4 $1.94
9/15/202295,500 shares $193,865.00 -2.7%0.7%1.6 $2.03
Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
8/31/202298,100 shares $195,219.00 +182.7%0.7%1.4 $1.99
8/15/202234,700 shares $58,296.00 -42.1%0.3%0.7 $1.68
7/31/202259,900 shares $86,855.00 -25.7%0.5%1.2 $1.45
7/15/202280,600 shares $124,930.00 -47.7%0.8%1.2 $1.55
6/30/2022154,200 shares $223,590.00 -29.3%1.6%0.2 $1.45
6/15/2022218,100 shares $307,521.00 -42.2%2.3%0.3 $1.41
5/31/2022377,300 shares $633,864.00 -2.8%2.9%0.6 $1.68
5/15/2022388,200 shares $543,480.00 -38.1%3.0%0.6 $1.40
4/30/2022627,000 shares $965,580.00 -49.8%5.0%0.7 $1.54
4/15/20221,250,000 shares $1.86 million +150.1%10.0%0.7 $1.49
3/31/2022499,900 shares $1.03 million -5.7%4.0%0.4 $2.07
3/15/2022530,100 shares $1.03 million -10.4%4.2%0.4 $1.95
2/28/2022591,700 shares $1.22 million -45.2%4.7%0.4 $2.07
2/15/20221,080,000 shares $2.39 million +425.3%8.5%0.8 $2.21
1/31/2022205,600 shares $380,360.00 -7.3%1.6%0.2 $1.85
1/15/2022221,700 shares $390,192.00 -13.8%1.7%1.5 $1.76
12/31/2021257,300 shares $499,162.00 +57.5%2.0%1.8 $1.94
12/15/2021163,400 shares $281,048.00 -30.9%1.3%1.2 $1.72
11/30/2021236,300 shares $484,415.00 -10.0%1.9%1.7 $2.05
11/15/2021262,600 shares $643,370.00 -10.5%2.1%1.9 $2.45
10/29/2021293,300 shares $821,240.00 +3.8%2.3%2.1 $2.80
10/15/2021282,700 shares $828,311.00 +8.7%2.2%2 $2.93
9/30/2021260,000 shares $816,400.00 +33.2%2.0%1.8 $3.14
9/15/2021195,200 shares $554,368.00 -0.9%1.5%1.4 $2.84
8/31/2021197,000 shares $581,150.00 -34.0%1.6%2.8 $2.95
8/13/2021298,300 shares $924,730.00 +5.3%2.3%4 $3.10
7/30/2021283,400 shares $940,888.00 -13.8%2.2%3.8 $3.32
7/15/2021328,900 shares $1.11 million -10.7%2.6%4.2 $3.36
6/30/2021368,200 shares $1.46 million +2.1%2.9%4.2 $3.97
6/15/2021360,500 shares $1.60 million -20.0%2.8%3.4 $4.43
5/28/2021450,400 shares $1.84 million +4.9%3.6%4.3 $4.09
5/14/2021429,300 shares $1.43 million +2.0%N/A3.6 $3.32
4/30/2021420,900 shares $1.49 million -0.2%N/A2.6 $3.54
4/15/2021421,900 shares $1.73 million -7.9%N/A1.8 $4.09
3/31/2021458,300 shares $1.82 million +68.4%N/A1.5 $3.98
3/15/2021272,200 shares $1.09 million +25.3%N/A0.5 $4.00
2/26/2021217,300 shares $873,546.00 +0.5%N/A0.1 $4.02
2/12/2021216,200 shares $1.08 million -63.5%N/A0.1 $4.98
1/29/2021591,600 shares $2.48 million -33.8%N/A0.2 $4.20
1/15/2021894,200 shares $3.35 million +49.8%N/A0.2 $3.75
12/31/2020597,100 shares $2.10 million +4,715.3%N/A0.2 $3.52
12/15/202012,400 shares $55,552.00 +9.7%N/A0 $4.48
11/30/202011,300 shares $26,555.00 -6.6%N/A0.2 $2.35
11/15/202012,100 shares $26,257.00 -57.4%N/A0.2 $2.17
10/30/202028,400 shares $58,220.00 +3.7%N/A0.3 $2.05
10/15/202027,400 shares $64,664.00 -9.9%N/A0.3 $2.36
9/30/202030,400 shares $69,008.00 +237.8%N/A0.3 $2.27
9/15/20209,000 shares $21,375.00 -61.9%N/A0 $2.38

BCDA Short Interest - Frequently Asked Questions

What is BioCardia's current short interest?

Short interest is the volume of BioCardia shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 262,800 shares of BCDA short. Learn More on BioCardia's current short interest.

What is a good short interest ratio for BioCardia?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCDA shares currently have a short interest ratio of 1.0. Learn More on BioCardia's short interest ratio.

Which institutional investors are shorting BioCardia?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioCardia: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is BioCardia's short interest increasing or decreasing?

BioCardia saw a drop in short interest in April. As of April 30th, there was short interest totaling 262,800 shares, a drop of 3.1% from the previous total of 271,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does BioCardia's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to BioCardia: Genetic Technologies Limited (0.58%), Organovo Holdings, Inc. (4.09%), Coeptis Therapeutics Holdings, Inc. (0.57%), Scinai Immunotherapeutics Ltd. (4.63%), Creative Medical Technology Holdings, Inc. (1.55%), Titan Pharmaceuticals, Inc. (1.99%), Fresh Tracks Therapeutics, Inc. (0.17%), Palisade Bio, Inc. (21.34%), Senti Biosciences, Inc. (1.05%), PharmaCyte Biotech, Inc. (0.17%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short BioCardia stock?

Short selling BCDA is an investing strategy that aims to generate trading profit from BioCardia as its price is falling. BCDA shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioCardia?

A short squeeze for BioCardia occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCDA, which in turn drives the price of the stock up even further.

How often is BioCardia's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCDA, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:BCDA) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners